Viewing Study NCT03937635


Ignite Creation Date: 2025-12-24 @ 10:45 PM
Ignite Modification Date: 2025-12-25 @ 8:15 PM
Study NCT ID: NCT03937635
Status: RECRUITING
Last Update Posted: 2025-11-13
First Post: 2019-04-24
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Sponsor: ECOG-ACRIN Cancer Research Group
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module